GLP-1 medications are safe to discontinue but in most cases, it isnt an ideal option
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss
To address this fear, clinicians should be knowledgeable about the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) study, which showed that insulin glargine 100 U/mL has a neutral effect on cardiovascular outcomes overall and a beneficial effect on microvascular complications, and the DEVOTE study, which established insulin degludec 100 U/mL as having a similar effect to insulin glargine 100 U/mL on the risk of cardiovascular events
In fact, many patients experience improved blood sugar control alongside weight loss
Factors such as rapid weight reduction, caloric restriction, nutritional deficiencies, and metabolic changes all play contributory roles
Prices that fall significantly below the industry average often indicate under-dosing or the presence of harmful contaminants